- Home
- DLHC vs OKYO Comparison
DLHC vs OKYO Comparison
Compare DLHC & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DLHC
- OKYO
- Stock Information
- Founded
- DLHC 1969
- OKYO 2007
- Country
- DLHC United States
- OKYO United Kingdom
- Employees
- DLHC N/A
- OKYO N/A
- Industry
- DLHC Business Services
- OKYO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DLHC Consumer Discretionary
- OKYO Health Care
- Exchange
- DLHC Nasdaq
- OKYO Nasdaq
- Market Cap
- DLHC 80.6M
- OKYO 77.9M
- IPO Year
- DLHC N/A
- OKYO 2022
- Fundamental
- Price
- DLHC $5.59
- OKYO $2.72
- Analyst Decision
- DLHC
- OKYO Strong Buy
- Analyst Count
- DLHC 0
- OKYO 1
- Target Price
- DLHC N/A
- OKYO $7.00
- AVG Volume (30 Days)
- DLHC 10.7K
- OKYO 192.5K
- Earning Date
- DLHC 12-03-2025
- OKYO 07-18-2025
- Dividend Yield
- DLHC N/A
- OKYO N/A
- EPS Growth
- DLHC 80.25
- OKYO N/A
- EPS
- DLHC 0.31
- OKYO N/A
- Revenue
- DLHC $359,723,000.00
- OKYO N/A
- Revenue This Year
- DLHC N/A
- OKYO N/A
- Revenue Next Year
- DLHC N/A
- OKYO N/A
- P/E Ratio
- DLHC $18.54
- OKYO N/A
- Revenue Growth
- DLHC N/A
- OKYO N/A
- 52 Week Low
- DLHC $2.72
- OKYO $0.90
- 52 Week High
- DLHC $9.58
- OKYO $3.35
- Technical
- Relative Strength Index (RSI)
- DLHC 58.98
- OKYO 62.42
- Support Level
- DLHC $5.53
- OKYO $2.11
- Resistance Level
- DLHC $5.88
- OKYO $2.70
- Average True Range (ATR)
- DLHC 0.16
- OKYO 0.17
- MACD
- DLHC 0.03
- OKYO 0.07
- Stochastic Oscillator
- DLHC 70.21
- OKYO 87.44
About DLHC DLH Holdings Corp.
DLH Holdings Corp is a provider of technology-enabled business process outsourcing and program management solutions in the United States. The company offers services to several government agencies which include the Department of Veteran Affairs. The company is engaged in public health, performance evaluation, and health operations to solve the complex problems faced by civilian and military customers alike, leveraging digital transformation, artificial intelligence, analytics, cloud-based applications, telehealth systems, and others.
About OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.